chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: 2nd dose missed; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (2nd dose missed) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017b21a) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (2nd dose missed). At the time of the report, PRODUCT DOSE OMISSION ISSUE (2nd dose missed) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications reported by reporter. Treatment medication not reported.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Blood pressure increased, Blood pressure measurement, Dizziness, Headache
Clinical narrative: blood pressure shot up; pulse went up to 114 beats per minute; felt woozy; sore arm; Weakness; headache; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD PRESSURE INCREASED (blood pressure shot up), HEART RATE INCREASED (pulse went up to 114 beats per minute), DIZZINESS (felt woozy), PAIN IN EXTREMITY (sore arm) and ASTHENIA (Weakness) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History Information Was Reported.     On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced BLOOD PRESSURE INCREASED (blood pressure shot up), HEART RATE INCREASED (pulse went up to 114 beats per minute), DIZZINESS (felt woozy), PAIN IN EXTREMITY (sore arm), ASTHENIA (Weakness) and HEADACHE (headache). The patient was treated with IBUPROFEN at an unspecified dose and frequency and IBUPROFEN at a dose of UNK dosage form. On 22-Jan-2021, BLOOD PRESSURE INCREASED (blood pressure shot up), HEART RATE INCREASED (pulse went up to 114 beats per minute) and DIZZINESS (felt woozy) had resolved. On 25-Jan-2021, PAIN IN EXTREMITY (sore arm), ASTHENIA (Weakness) and HEADACHE (headache) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Jan-2021, Blood pressure measurement: increased (High) blood pressure shot up. On 22-Jan-2021, Heart rate: 114 (High) 114 beats per minute.     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medication information was reported.     Most recent FOLLOW-UP information incorporated above includes: On 21-Jun-2021: Follow up Information received on 21-jun-2021and contains no new information.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Heart rate, Heart rate increased, Pain in extremity
Clinical narrative: blood pressure shot up; pulse went up to 114 beats per minute; felt woozy; sore arm; Weakness; headache; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD PRESSURE INCREASED (blood pressure shot up), HEART RATE INCREASED (pulse went up to 114 beats per minute), DIZZINESS (felt woozy), PAIN IN EXTREMITY (sore arm) and ASTHENIA (Weakness) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History Information Was Reported.     On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced BLOOD PRESSURE INCREASED (blood pressure shot up), HEART RATE INCREASED (pulse went up to 114 beats per minute), DIZZINESS (felt woozy), PAIN IN EXTREMITY (sore arm), ASTHENIA (Weakness) and HEADACHE (headache). The patient was treated with IBUPROFEN at an unspecified dose and frequency and IBUPROFEN at a dose of UNK dosage form. On 22-Jan-2021, BLOOD PRESSURE INCREASED (blood pressure shot up), HEART RATE INCREASED (pulse went up to 114 beats per minute) and DIZZINESS (felt woozy) had resolved. On 25-Jan-2021, PAIN IN EXTREMITY (sore arm), ASTHENIA (Weakness) and HEADACHE (headache) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Jan-2021, Blood pressure measurement: increased (High) blood pressure shot up. On 22-Jan-2021, Heart rate: 114 (High) 114 beats per minute.     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medication information was reported.     Most recent FOLLOW-UP information incorporated above includes: On 21-Jun-2021: Follow up Information received on 21-jun-2021and contains no new information.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine administered after it was stored at room temperature for 18 hours; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine administered after it was stored at room temperature for 18 hours) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine administered after it was stored at room temperature for 18 hours). On 15-Jun-2021, EXPIRED PRODUCT ADMINISTERED (Vaccine administered after it was stored at room temperature for 18 hours) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were provided by the reporter.
Sex: M
Vaccine: COVID19
Symptoms: Chills
Clinical narrative: chilly; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chilly) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced CHILLS (chilly). At the time of the report, CHILLS (chilly) had resolved.            No concomitant medications were provided.  No treatment information provided.   This case was linked to MOD-2021-067699 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Sex: U
Vaccine: COVID19
Symptoms: Wrong product administered
Clinical narrative: Wrong Vaccine Administered; This spontaneous case was reported by a consumer and describes the occurrence of WRONG PRODUCT ADMINISTERED (Wrong Vaccine Administered) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced WRONG PRODUCT ADMINISTERED (Wrong Vaccine Administered). At the time of the report, WRONG PRODUCT ADMINISTERED (Wrong Vaccine Administered) had resolved.            No concomitant medications were provided.  No treatment information provided.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Mental disorder
Clinical narrative: crazy for about a week; This spontaneous case was reported by a consumer and describes the occurrence of MENTAL DISORDER (crazy for about a week) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MENTAL DISORDER (crazy for about a week). At the time of the report, MENTAL DISORDER (crazy for about a week) outcome was unknown.            Concomitant information use was not reported.  Treatment information was not provided.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Epistaxis, Fatigue, Nausea
Clinical narrative: nausea; run diwn; nose bleed; diarrhoea; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nausea), FATIGUE (run diwn), EPISTAXIS (nose bleed) and DIARRHOEA (diarrhoea) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Percodan), Food allergy (Tomatoes), Food allergy (Strawberries) and COPD. Concomitant products included ALPRAZOLAM for Anxiety, ALENDRONATE SODIUM (FOSAMAX), LAMOTRIGINE (LAMICTAL), METOPROLOL SUCCINATE (TOPROL XL) and PREDNISONE for an unknown indication.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced NAUSEA (nausea), FATIGUE (run diwn), EPISTAXIS (nose bleed) and DIARRHOEA (diarrhoea). At the time of the report, NAUSEA (nausea), FATIGUE (run diwn) and DIARRHOEA (diarrhoea) had not resolved and EPISTAXIS (nose bleed) had resolved. Not Provided          No treatment information was reported.   This case was linked to MOD-2021-089419.
Sex: F
Vaccine: COVID19
Symptoms: Aphasia, Burning sensation, Diarrhoea, Diplopia, Dysgeusia
Clinical narrative: APHASIA; LYMPHOEDEMA; DIPLOPIA; DYSGEUSIA; BURNING SENSATION; DIARRHOEA; Pain in extremity; RASH; HEADACHE; FATIGUE; This spontaneous case was reported by a consumer and describes the occurrence of APHASIA (APHASIA), LYMPHOEDEMA (LYMPHOEDEMA), DIPLOPIA (DIPLOPIA), DYSGEUSIA (DYSGEUSIA) and BURNING SENSATION (BURNING SENSATION) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 01-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced APHASIA (APHASIA), LYMPHOEDEMA (LYMPHOEDEMA), DIPLOPIA (DIPLOPIA), DYSGEUSIA (DYSGEUSIA), BURNING SENSATION (BURNING SENSATION), DIARRHOEA (DIARRHOEA), PAIN IN EXTREMITY (Pain in extremity), RASH (RASH), HEADACHE (HEADACHE) and FATIGUE (FATIGUE). At the time of the report, APHASIA (APHASIA), LYMPHOEDEMA (LYMPHOEDEMA), DIPLOPIA (DIPLOPIA), DYSGEUSIA (DYSGEUSIA), BURNING SENSATION (BURNING SENSATION), DIARRHOEA (DIARRHOEA), PAIN IN EXTREMITY (Pain in extremity), RASH (RASH), HEADACHE (HEADACHE) and FATIGUE (FATIGUE) outcome was unknown.            Concomitant medication was not reported.  No treatment medication was reported.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Lymphoedema, Pain in extremity, Rash
Clinical narrative: APHASIA; LYMPHOEDEMA; DIPLOPIA; DYSGEUSIA; BURNING SENSATION; DIARRHOEA; Pain in extremity; RASH; HEADACHE; FATIGUE; This spontaneous case was reported by a consumer and describes the occurrence of APHASIA (APHASIA), LYMPHOEDEMA (LYMPHOEDEMA), DIPLOPIA (DIPLOPIA), DYSGEUSIA (DYSGEUSIA) and BURNING SENSATION (BURNING SENSATION) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 01-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced APHASIA (APHASIA), LYMPHOEDEMA (LYMPHOEDEMA), DIPLOPIA (DIPLOPIA), DYSGEUSIA (DYSGEUSIA), BURNING SENSATION (BURNING SENSATION), DIARRHOEA (DIARRHOEA), PAIN IN EXTREMITY (Pain in extremity), RASH (RASH), HEADACHE (HEADACHE) and FATIGUE (FATIGUE). At the time of the report, APHASIA (APHASIA), LYMPHOEDEMA (LYMPHOEDEMA), DIPLOPIA (DIPLOPIA), DYSGEUSIA (DYSGEUSIA), BURNING SENSATION (BURNING SENSATION), DIARRHOEA (DIARRHOEA), PAIN IN EXTREMITY (Pain in extremity), RASH (RASH), HEADACHE (HEADACHE) and FATIGUE (FATIGUE) outcome was unknown.            Concomitant medication was not reported.  No treatment medication was reported.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered, Feeling abnormal, Injection site pain, Somnolence
Clinical narrative: she went back to the vaccie clinic the same day and was given an additional dose; felt groggy and foggy; felt groggy and foggy; a sore arm  which lasted about 24 hours; This spontaneous case was reported by a consumer and describes the occurrence of EXTRA DOSE ADMINISTERED (she went back to the vaccie clinic the same day and was given an additional dose), FEELING ABNORMAL (felt groggy and foggy), SOMNOLENCE (felt groggy and foggy) and INJECTION SITE PAIN (a sore arm  which lasted about 24 hours) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 07-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, the patient experienced EXTRA DOSE ADMINISTERED (she went back to the vaccie clinic the same day and was given an additional dose), FEELING ABNORMAL (felt groggy and foggy), SOMNOLENCE (felt groggy and foggy) and INJECTION SITE PAIN (a sore arm  which lasted about 24 hours). On 07-Apr-2021, EXTRA DOSE ADMINISTERED (she went back to the vaccie clinic the same day and was given an additional dose), FEELING ABNORMAL (felt groggy and foggy) and SOMNOLENCE (felt groggy and foggy) had resolved. On 08-Apr-2021, INJECTION SITE PAIN (a sore arm  which lasted about 24 hours) had resolved.            No concomitant medication details was reported. No treatment medication details was reported.   This case was linked to MOD-2021-069691 (Patient Link).
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: arm aching; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm aching) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (arm aching). At the time of the report, PAIN IN EXTREMITY (arm aching) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.  No relevant Lab Data was provided.  No relevant medical history was provided.   This case was linked to MOD-2021-072551 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 14-Jul-2021: Follow-up information received on 14 Jul 2021 contains non-significant information.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Injection site pain, Malaise
Clinical narrative: Fever; Injection site pain; Feeling unwell; Tiredness; Headache; Chills; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Feeling unwell), FATIGUE (Tiredness), HEADACHE (Headache), CHILLS (Chills) and PYREXIA (Fever) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B2114) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (Sulfa products). Concomitant products included CHLORPHENAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, PARACETAMOL, PSEUDOEPHEDRINE HYDROCHLORIDE (MULTI SYMPTOM TYLENOL COLD) for an unknown indication.    On 04-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced MALAISE (Feeling unwell), FATIGUE (Tiredness), HEADACHE (Headache) and CHILLS (Chills). On an unknown date, the patient experienced PYREXIA (Fever) and INJECTION SITE PAIN (Injection site pain). At the time of the report, MALAISE (Feeling unwell), FATIGUE (Tiredness), HEADACHE (Headache), CHILLS (Chills), PYREXIA (Fever) and INJECTION SITE PAIN (Injection site pain) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided by the reporter.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test
Clinical narrative: Fever; Injection site pain; Feeling unwell; Tiredness; Headache; Chills; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Feeling unwell), FATIGUE (Tiredness), HEADACHE (Headache), CHILLS (Chills) and PYREXIA (Fever) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B2114) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (Sulfa products). Concomitant products included CHLORPHENAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, PARACETAMOL, PSEUDOEPHEDRINE HYDROCHLORIDE (MULTI SYMPTOM TYLENOL COLD) for an unknown indication.    On 04-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced MALAISE (Feeling unwell), FATIGUE (Tiredness), HEADACHE (Headache) and CHILLS (Chills). On an unknown date, the patient experienced PYREXIA (Fever) and INJECTION SITE PAIN (Injection site pain). At the time of the report, MALAISE (Feeling unwell), FATIGUE (Tiredness), HEADACHE (Headache), CHILLS (Chills), PYREXIA (Fever) and INJECTION SITE PAIN (Injection site pain) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Nausea
Clinical narrative: Dizziness; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness) and NAUSEA (Nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Dizziness) and NAUSEA (Nausea). At the time of the report, DIZZINESS (Dizziness) and NAUSEA (Nausea) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were provided.  No treatment medication were provided.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: Positive COVID test; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Positive COVID test) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011520A) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Jan-2021, the patient experienced COVID-19 (Positive COVID test). At the time of the report, COVID-19 (Positive COVID test) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Jan-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided No Treatment information provided
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Swollen lymph nodes in the arm pit; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (Swollen lymph nodes in the arm pit) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Mar-2021, the patient experienced LYMPHADENOPATHY (Swollen lymph nodes in the arm pit). The patient was treated with PARACETAMOL (TYLENOL) for Swollen lymph nodes, at a dose of 1 dosage form. At the time of the report, LYMPHADENOPATHY (Swollen lymph nodes in the arm pit) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was provided
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: COVID arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (COVID arm) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (COVID arm). At the time of the report, VACCINATION COMPLICATION (COVID arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medication details were provided. No treatment medication details were provided.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain
Clinical narrative: Back pain; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Back pain) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031M20A and 011L20A) for COVID-19 vaccination.     Concurrent medical conditions included Myeloma (Multiple Myeloma was reported).   On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Mar-2021, the patient experienced BACK PAIN (Back pain). At the time of the report, BACK PAIN (Back pain) outcome was unknown.            patient took chemo pills 3 weeks No treatment medication were reported.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Gait disturbance, Nausea
Clinical narrative: Feeling very very tired, feeling kind of washed out, tired, he felt like laying down, going to sleep and not waking up; Difficulty in walking; Chills; Tiredness; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Feeling very very tired, feeling kind of washed out, tired, he felt like laying down, going to sleep and not waking up), GAIT DISTURBANCE (Difficulty in walking), CHILLS (Chills), FATIGUE (Tiredness) and NAUSEA (Nausea) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0Z6A21A) for COVID-19 vaccination.     Concurrent medical conditions included Arthritis and Muscle disorder NOS.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Mar-2021, the patient experienced SOMNOLENCE (Feeling very very tired, feeling kind of washed out, tired, he felt like laying down, going to sleep and not waking up), GAIT DISTURBANCE (Difficulty in walking), CHILLS (Chills), FATIGUE (Tiredness) and NAUSEA (Nausea). At the time of the report, SOMNOLENCE (Feeling very very tired, feeling kind of washed out, tired, he felt like laying down, going to sleep and not waking up), GAIT DISTURBANCE (Difficulty in walking), CHILLS (Chills), FATIGUE (Tiredness) and NAUSEA (Nausea) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: inconclusive (Inconclusive) Not fever, he measured his temperature just in case.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Somnolence
Clinical narrative: Feeling very very tired, feeling kind of washed out, tired, he felt like laying down, going to sleep and not waking up; Difficulty in walking; Chills; Tiredness; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Feeling very very tired, feeling kind of washed out, tired, he felt like laying down, going to sleep and not waking up), GAIT DISTURBANCE (Difficulty in walking), CHILLS (Chills), FATIGUE (Tiredness) and NAUSEA (Nausea) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0Z6A21A) for COVID-19 vaccination.     Concurrent medical conditions included Arthritis and Muscle disorder NOS.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Mar-2021, the patient experienced SOMNOLENCE (Feeling very very tired, feeling kind of washed out, tired, he felt like laying down, going to sleep and not waking up), GAIT DISTURBANCE (Difficulty in walking), CHILLS (Chills), FATIGUE (Tiredness) and NAUSEA (Nausea). At the time of the report, SOMNOLENCE (Feeling very very tired, feeling kind of washed out, tired, he felt like laying down, going to sleep and not waking up), GAIT DISTURBANCE (Difficulty in walking), CHILLS (Chills), FATIGUE (Tiredness) and NAUSEA (Nausea) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: inconclusive (Inconclusive) Not fever, he measured his temperature just in case.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Lethargy
Clinical narrative: lethargy; flu like symptoms; This spontaneous case was reported by a pharmacist and describes the occurrence of LETHARGY (lethargy) and INFLUENZA LIKE ILLNESS (flu like symptoms) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013l20a) for COVID-19 vaccination.     The patient's past medical history included Crohn's disease on 01-Jan-2000 and Cold symptoms from 2020 to 06-Jan-2021. Concomitant products included 6-MERCAPTOPURINE MONOHYDRATE for Crohn's.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced LETHARGY (lethargy) and INFLUENZA LIKE ILLNESS (flu like symptoms). At the time of the report, LETHARGY (lethargy) and INFLUENZA LIKE ILLNESS (flu like symptoms) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not reported.   This case was linked to MOD-2021-003502 (Patient Link).
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 17 year old was given prime dose of Moderna vaccine; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old was given prime dose of Moderna vaccine) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old was given prime dose of Moderna vaccine). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old was given prime dose of Moderna vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided. No treatment medication was provided.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore Arm) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore Arm). The patient was treated with NAPROXEN SODIUM (ALEVE) for Pain in arm, at a dose of 1 dosage form. On 14-Jan-2021, PAIN IN EXTREMITY (Sore Arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-223844 (Patient Link).
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle spasms
Clinical narrative: Back went into spasms; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (Back went into spasms) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 03-Mar-2021, the patient experienced MUSCLE SPASMS (Back went into spasms). At the time of the report, MUSCLE SPASMS (Back went into spasms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       patient stated that she has had back issues and its not related to vaccine. she also stated  she had injections for it in November and December.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Vaccination site pain
Clinical narrative: Sore Arm; Chills; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore Arm) and CHILLS (Chills) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K20A and 010M20A) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE, LISINOPRIL and ATORVASTATIN for an unknown indication.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Feb-2021, the patient experienced VACCINATION SITE PAIN (Sore Arm) and CHILLS (Chills). The patient was treated with NAPROXEN SODIUM (ALEVE) at a dose of 1 dosage form. On 12-Feb-2021, VACCINATION SITE PAIN (Sore Arm) and CHILLS (Chills) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-223842 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Paraesthesia oral, Swelling face
Clinical narrative: Tongue is tingly; Cheeks feel a little puffy; Arm is mildly sore; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA ORAL (Tongue is tingly), SWELLING FACE (Cheeks feel a little puffy) and PAIN IN EXTREMITY (Arm is mildly sore) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, the patient experienced PARAESTHESIA ORAL (Tongue is tingly), SWELLING FACE (Cheeks feel a little puffy) and PAIN IN EXTREMITY (Arm is mildly sore). At the time of the report, PARAESTHESIA ORAL (Tongue is tingly), SWELLING FACE (Cheeks feel a little puffy) and PAIN IN EXTREMITY (Arm is mildly sore) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medications were not provided.
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, Nervousness, Vaccination site pain
Clinical narrative: feels really really nervous; HCP strongly thinks the vaccine was administered subcutaneously; soreness in the triceps area; This spontaneous case was reported by an other health care professional and describes the occurrence of NERVOUSNESS (feels really really nervous), INCORRECT DOSE ADMINISTERED (HCP strongly thinks the vaccine was administered subcutaneously) and VACCINATION SITE PAIN (soreness in the triceps area) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced NERVOUSNESS (feels really really nervous), INCORRECT DOSE ADMINISTERED (HCP strongly thinks the vaccine was administered subcutaneously) and VACCINATION SITE PAIN (soreness in the triceps area). On 15-Jan-2021, INCORRECT DOSE ADMINISTERED (HCP strongly thinks the vaccine was administered subcutaneously) had resolved. At the time of the report, NERVOUSNESS (feels really really nervous) and VACCINATION SITE PAIN (soreness in the triceps area) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Illness, Musculoskeletal chest pain, Pain, Peripheral swelling
Clinical narrative: Swollen leg; Pain; Very sick; sore under arm; sore rib cage, cannot rock side to side; Pain in the same arm of injection; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swollen leg), PAIN (Pain), ILLNESS (Very sick), AXILLARY PAIN (sore under arm) and MUSCULOSKELETAL CHEST PAIN (sore rib cage, cannot rock side to side) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (Swollen leg), PAIN (Pain), ILLNESS (Very sick), AXILLARY PAIN (sore under arm), MUSCULOSKELETAL CHEST PAIN (sore rib cage, cannot rock side to side) and VACCINATION SITE PAIN (Pain in the same arm of injection). At the time of the report, PERIPHERAL SWELLING (Swollen leg), PAIN (Pain), ILLNESS (Very sick), AXILLARY PAIN (sore under arm), MUSCULOSKELETAL CHEST PAIN (sore rib cage, cannot rock side to side) and VACCINATION SITE PAIN (Pain in the same arm of injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not reported.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Swollen leg; Pain; Very sick; sore under arm; sore rib cage, cannot rock side to side; Pain in the same arm of injection; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swollen leg), PAIN (Pain), ILLNESS (Very sick), AXILLARY PAIN (sore under arm) and MUSCULOSKELETAL CHEST PAIN (sore rib cage, cannot rock side to side) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (Swollen leg), PAIN (Pain), ILLNESS (Very sick), AXILLARY PAIN (sore under arm), MUSCULOSKELETAL CHEST PAIN (sore rib cage, cannot rock side to side) and VACCINATION SITE PAIN (Pain in the same arm of injection). At the time of the report, PERIPHERAL SWELLING (Swollen leg), PAIN (Pain), ILLNESS (Very sick), AXILLARY PAIN (sore under arm), MUSCULOSKELETAL CHEST PAIN (sore rib cage, cannot rock side to side) and VACCINATION SITE PAIN (Pain in the same arm of injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not reported.
Age: 95.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia
Clinical narrative: Fatigue; Headache; Muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue), HEADACHE (Headache) and MYALGIA (Muscle pain) in a 95-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced FATIGUE (Fatigue), HEADACHE (Headache) and MYALGIA (Muscle pain). At the time of the report, FATIGUE (Fatigue), HEADACHE (Headache) and MYALGIA (Muscle pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication reported.  No treatment information provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 30-Jun-2021: Follow up received and contains no new information
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Discomfort, Fatigue, Lymphadenopathy, Pain
Clinical narrative: Weakness; Discomfort in Arm,under left Armpit; Slight pain in the body; Swelling in left armpit near lymph glands; Tiredness; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Weakness), DISCOMFORT (Discomfort in Arm, under left Armpit), PAIN (Slight pain in the body), LYMPHADENOPATHY (Swelling in left armpit near lymph glands) and FATIGUE (Tiredness) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jun-2021, the patient experienced ASTHENIA (Weakness), DISCOMFORT (Discomfort in Arm, under left Armpit), PAIN (Slight pain in the body), LYMPHADENOPATHY (Swelling in left armpit near lymph glands) and FATIGUE (Tiredness). At the time of the report, ASTHENIA (Weakness), DISCOMFORT (Discomfort in Arm,under left Armpit), PAIN (Slight pain in the body) and FATIGUE (Tiredness) outcome was unknown and LYMPHADENOPATHY (Swelling in left armpit near lymph glands) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant information was provided. No treatment information was provided by the reporter.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Tinnitus
Clinical narrative: Ringing in the ears; Cough; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (Ringing in the ears) and COUGH (Cough) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M20A and 011L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Feb-2021, the patient experienced TINNITUS (Ringing in the ears) and COUGH (Cough). At the time of the report, TINNITUS (Ringing in the ears) and COUGH (Cough) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable.  No concomitant medications were reported. Treatment information was unknown.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: sore arm at the injection site; This spontaneous case was reported by a non-health professional and describes the occurrence of INJECTION SITE PAIN (sore arm at the injection site) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     No medical history reported by reporter.  Concomitant products included WARFARIN from 11-Feb-2021 to an unknown date for an unknown indication.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INJECTION SITE PAIN (sore arm at the injection site). At the time of the report, INJECTION SITE PAIN (sore arm at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medication was provided.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Pyrexia
Clinical narrative: Fatigue; Joint Pain; Fever; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue), ARTHRALGIA (Joint Pain) and PYREXIA (Fever) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011L20A and 013M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Jan-2021, the patient experienced FATIGUE (Fatigue), ARTHRALGIA (Joint Pain) and PYREXIA (Fever). At the time of the report, FATIGUE (Fatigue), ARTHRALGIA (Joint Pain) and PYREXIA (Fever) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Potential Missed Window for Vaccination; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Potential Missed Window for Vaccination) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L2OA) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Potential Missed Window for Vaccination). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Potential Missed Window for Vaccination) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported. The treatment information was not given.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Heart rate, Palpitations, Product dose omission issue
Clinical narrative: 2nd shot past due; palpitations; felt jittery inside of her chest; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (palpitations), CHEST DISCOMFORT (felt jittery inside of her chest) and PRODUCT DOSE OMISSION ISSUE (2nd shot past due) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. o24m20a) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure abnormal.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced CHEST DISCOMFORT (felt jittery inside of her chest). On 24-Feb-2021, the patient experienced PALPITATIONS (palpitations). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (2nd shot past due). At the time of the report, PALPITATIONS (palpitations), CHEST DISCOMFORT (felt jittery inside of her chest) and PRODUCT DOSE OMISSION ISSUE (2nd shot past due) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Feb-2021, Heart rate: abnormal (abnormal) Fast heart beat.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication included blood pressure meds.  No treatment information provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 30-Jun-2021: Info regarding 2nd dose updated
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Potential missed window for vaccination; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Potential missed window for vaccination) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L2OA) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Potential missed window for vaccination). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Potential missed window for vaccination) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No information about concomitant medication was provided.  No information about treatment medication was provided.